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Background: Over 40% of patients with end stage renal disease in the United States were treated with home
hemodialysis (HHD) in the early 1970’s. However, this number declined rapidly over the ensuing decades so that the
overwhelming majority of patients were treated in-centre 3 times per week on a 3-4 hour schedule. Poor outcomes for
patients treated in this fashion led to a renewed interest in home hemodialysis, with more intensive dialysis schedules
including short daily (SDHD) and nocturnal (NHD). The relative infancy of these treatment schedules means that there
is a paucity of data on ‘how to do it’.
Objective: We undertook a systematic survey of home hemodialysis programs in Canada to describe current practice
patterns.
Design: Development and deployment of a qualitative survey instrument.
Setting: Community and academic HHD programs in Canada.
Participants: Physicians, nurses and technologists.
Measurements: Programmatic approaches to patient selection, delivery of dialysis, human resources available, and
follow up.
Methods: We developed the survey instrument in three phases. A focus group of Canadian nephrologists with
expertise in NHD or SDHD discussed the scope the study and wrote questions on 11 domains. Three nephrologists
familiar with all aspects of HHD delivery reviewed this for content validity, followed by further feedback from the whole
group. Multidisciplinary teams at three sites pretested the survey and further suggestions were incorporated. In July
2010 we distributed the survey electronically to all renal programs known to offer HHD according to the Canadian
Organ Replacement Registry.
We compiled the survey results using qualitative and quantitative methods, as appropriate.
Results: Of the academic and community programs that were invited to participate, 80% and 63%, respectively,
completed the survey. We observed wide variation in programmatic approaches to patient recruitment, human
resources, equipment, water, vascular access, patient training, dialysis prescription, home requirements, patient follow
up, medications, and the approach to non-adherent patients.
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Limitations: Cross-sectional survey, unable to link variation to outcomes. Competition for patients between HHD and
home peritoneal dialysis means that case mix for HHD may also vary between centres.
Conclusions: There is wide variation between programs in all domains of HHD delivery in Canada. We plan further
study of the extent to which differences in approach are related to outcomes.
Keywords: Intensive hemodialysis, Nocturnal, Short daily, Survey, Practice patternsAbstract
Problématique: Au début des années 70, plus de 40% des patients en insuffisance rénale terminale aux États-Unis
étaient traités par hémodialyse à domicile (HDD). Cette proportion a décliné rapidement au cours des décennies
suivantes, de sorte que le mode de suppléance pour la majorité des patients est maintenant l’hémodialyse 3 fois
par semaine à raison de 3 à 4 heures par séance. Les mauvais résultats obtenus avec cette méthode ont renouvelé
l’intérêt pour l’HDD, notamment pour les dialyses intensives incluant la dialyse quotidienne courte (DQC) et
l’hémodialyse nocturne (HDN). Étant donné leur nouveauté, il y a peu de données sur les façons de faire avec ces
modes de suppléance.
Objectif: Afin de décrire les pratiques actuelles, nous avons réalisé un questionnaire systématique auprès des
programmes d’HDD au Canada.
Design: Développement et déploiement d’un outil qualitatif.
Cadre: Programmes d’HDD académiques et communautaires au Canada
Participants: Médecins, infirmières et technologues
Variables mesurées: Approches pour la sélection des patients, le mode de suppléance, les ressources humaines
disponibles et le mode de suivi pour chaque programme
Méthodologie: Nous avons développé un outil en trois phases. Un groupe de discussion composé de
néphrologues canadiens ayant une expertise en DQC ou HDN ont échangé sur le contenu de l’étude et ont rédigé
des questions sur 11 domaines. Trois néphrologues familiers avec tous les aspects de l’HDD ont révisé la validité
des questions, puis ont demandé un nouvel avis à tout le groupe de discussion. Des équipes multidisciplinaires
provenant de trois sites ont ensuite évalué le questionnaire et ont apporté des suggestions. En juillet 2010, le
questionnaire a été distribué électroniquement à tous les programmes qui offrent l’HDD d’après le Registre
canadien des insuffisances et des transplantations d’organes.
Les résultats ont été compilés au moyen de méthodes qualitatives ou quantitatives, le cas échéant.
Résultats: 80% des centres académiques et 63% des centres communautaires invités ont répondu au
questionnaire. Nous avons observé des variations importantes entre les programmes quant au recrutement des
patients, aux ressources humaines, à l’équipement, à l’eau, aux accès vasculaires, à l’entraînement des patients, à la
prescription de dialyse, aux exigences du domicile, au suivi des patients, à la médication et à l’approche face aux
patients non-adhérents.
Limitations: Étude transversale, incapacité d’associer les variations aux issues cliniques. La compétition entre l’HDD
et la dialyse péritonéale pour le recrutement des patients entraîne peut-être une variabilité entre les centres dans la
composition des groupes de patients en HDD.
Conclusions: Il y a de grandes variations entre les programmes dans tous les domaines concernant l’HDD au
Canada. Nous planifions d’étudier dans le futur jusqu’à quel point ces différences sont reliées aux issues cliniques.
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Home hemodialysis has its origins in the earliest era of
renal replacement therapy. Forty percent of all end-stage
renal disease (ESRD) patients in the United States were dia-
lyzing at home in the early 1970s [1]. Over the following
decades, home dialysis fell out of favor being largely re-
placed by conventional thrice-weekly facility-based hemo-
dialysis with 3.5-4 hour treatments in much of the world.
Factors such as the unacceptably high mortality associated
with ESRD [2], the negative outcomes of the HEMO study
[3], and a growing body of literature espousing the benefits
of more frequent, intensive hemodialysis prescriptions have
spurred resurgent interest in home-based dialysis treat-
ments [4-8].
The two predominant paradigms of home hemodialysis
(HHD) are nocturnal hemodialysis (NHD) where patients
typically dialyze 3.5-6 nights per week with 6–8 hour ses-
sions, and short daily hemodialysis (SDHD) consisting of
5–6 treatments per week with 1.5-2.5 hour sessions. Both
modalities are associated with physiological, quality of life,
and survival benefits compared to conventional, facility-
based hemodialysis [4,5,9-11]. Logistic and economic con-
siderations dictate that most facility-based hemodialysis
units cannot easily deliver NHD or SDHD, so that these
therapies are ideally performed in the home environment.
Many regional dialysis programs have combined their con-
siderable expertise of providing home-based hemodialysis
from an earlier era with contemporary NHD or SDHD pre-
scriptions. Anecdotally, this has resulted in variation in
practice patterns pertaining to domains such as patient re-
cruitment, training, and follow-up among HHD programs.
We recently reported on patient and technique survival
in a multicenter NHD cohort and found a significant cen-
ter effect, suggesting that variation in program-level clinical
care (in addition to differences in case mix) plays an im-
portant role in determining adverse outcomes [12]. Indeed,
retention to HHD programs in Canada and the United
States varies from 64% to 95% at 12 months, further under-
scoring the need to characterize both patient- and
program-specific variables that may explain these dif-
ferences [12-14]. Importantly, while patient factors predic-
ting poor technique survival or adverse health outcomes
are often not-modifiable, program related factors can often
be adapted to reflect practices associated with the best out-
comes. To date, a granular catalogue of practice patterns
for home hemodialysis has not been undertaken so it re-
mains unclear precisely how much variation exists, and
which variables might affect outcomes. Here we report on
a systematic survey of HHD practice patterns across
Canada.
Methods
A survey instrument was developed between May and July
2010 in three phases. Phase 1 – a focus group of Canadiannephrologists with clinical experience in providing NHD
and/or SDHD discussed the scope of practice patterns to
be interrogated. Each of the 10 nephrologists was charged
with writing questions for one or more domains pertain-
ing to program recruitment, human resources, equipment,
water, vascular access, patient training, dialysis prescrip-
tion, home requirements, patient follow-up, medications,
and non-adherent patients. Phase 2 – all questions were
compiled and a draft survey was screened by three
nephrologists familiar in all aspects of HHD delivery (D.L.
Z., P.K., and R.P.P.) for content revision and completeness.
A revised draft was circulated to the entire group for feed-
back resulting in further editing. Phase 3 – a pilot ques-
tionnaire was sent to three test centres where it was
reviewed by an HHD nephrologist, a nurse manager, the
nursing staff responsible for HHD patient care, and the
HHD technologist staff. Feedback was incorporated into
the survey instrument by the primary investigators (D.L.
Z., P.K., and R.P.P.). In addition to the questions pertain-
ing to the aforementioned domains of HHD care, the final
questionnaire also incorporated questions regarding ESRD
program information. Program details included the total
number of ESRD patients treated, the modality distri-
bution of those patients, as well as the specific distribu-
tion of HHD modalities (ie. NHD, SDHD, conventional
hemodialysis, or a hybrid prescription). The complete
questionnaire is available in Additional file 1.
In July 2010 the survey was sent electronically to all
academic and community renal programs known to offer
HHD according to the Canadian Organ Replacement
Registry (CORR). Programs were encouraged to complete
the questionnaires jointly between physicians, nursing
staff, and technologists. Frequent reminders (maximum of
3) were circulated to encourage completion; data was col-
lated in February 2011. Summary responses by domain
are reported here.
Results and discussion
Of the 15 academic renal programs and 8 community pro-
grams surveyed, 12 (80%) and 5 (63%) completed the
survey respectively. Within these programs, the mean
(±stddev) prevalent use of home dialysis modalities was
24.4 ± 8.4% (range 8.5-42.8%) of the ESRD population
(mean 17.5% peritoneal dialysis [PD], 6.9% HHD) (Table 1).
For patients receiving HHD, 68.2% were treated with
NHD, 9.9% with SDHD (9.9%); the remainder were treated
with a hybrid prescription or conventional thrice weekly
HD.
Program recruitment
The majority of programs (76.5%) reported a specific
strategy for recruiting patients to HHD, with 82.4%
having a designated education session for patients with
advanced CKD. This questionnaire did not assess the






















C = community (% total) (% total) (% total) (% total) (% total) (% total) (% HHD) (% HHD) (% HHD)
1 A 399 69.9% 26.1% 1.8% 27.9% 2.3% 0% 85.7% 14.3% 0%
2 A 656 62.5% 23.0% 14.5% 37.5% 0% 0% 91.6% 8.4% 0%
3 A 958 69.4% 21.7% 6.6% 28.3% 2.3% 0% 73.0% 1.6% 25.4%
4 A 1267 77.3% 19.7% 2.1% 21.8% 0.9% 0% 33.3% 0% 66.7%
5 A 817 74.2% 19.7% 4.3% 24.0% 1.5% 0.4% 65.7% 20.0% 14.3%
6 A 513 77.0% 18.9% 2.1% 21.0% 1.9% 0% 63.6% 18.2% 18.2%
7 A 191 68.1% 18.8% 12.0% 30.8% 1.0% 0% 91.3% 0% 8.7%
8 A 983 77.4% 16.0% 4.8% 20.8% 0.6% 1.2% 57.4% 4.3% 38.3%
9 A 552 65.2% 14.5% 15.7% 30.2% 3.6% 1.3% 76.5% 17.6% 5.9%
10 A 746 75.6% 13.4% 5.5% 18.9% 5.5% 0% 36.6% 17.1% 46.3%
11 A 549 69.9% 11.8% 8.2% 20.0% 10.4% 0% 24.4% 17.8% 57.8%
12 A 187 91.4% 4.8% 3.7% 8.5% 0% 0% 85.7% 0% 14.3%
13 C 385 54.0% 31.4% 11.4% 42.8% 3.1% 0% 56.8% 40.9% 2.3%
14 C 232 74.1% 22.0% 3.0% 25.0% 0.9% 0% 57.2% 0% 42.8%
15 C 493 75.1% 16.8% 3.4% 20.2% 4.7% 0% 94.1% 0% 5.9%
16 C 415 84.3% 9.6% 2.4% 12.0% 3.6% 0% 81.8% 0% 18.2%
17 C 446 70.4% 9.9% 15.2% 25.1% 4.5% 0% 85.3% 7.4% 7.4%
Mean 72.7% 17.5% 6.9% 24.4% 2.3% 0.2% 68.2% 9.8% 21.9%
Median 74.1% 18.8% 4.8% 24.0% 2.3% 0.0% 73.0% 7.4% 14.3%
Standard Deviation 8.4% 6.6% 5.0% 8.4% 2.6% 0.4% 21.6% 11.2% 20.9%
HD, hemodialysis; NHD, nocturnal hemodialysis; SDHD, short-daily hemodialysis; PD, peritoneal dialysis; HHD, home hemodialysis (consisting of all forms of NHD, SDHD and non-NHD/non-SDHD home hemodialysis).
1NHD: consisting of any NHD prescription including thrice weekly, every-other-night, or 4–6 times per week.
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sions). Recruitment aids for HHD included videos (58.8%
of programs use this aid), posters (64.7%), targeted moda-
lity education classes (64.7%), modality education nurses
(70.6%) and discussions about patient eligibility at patient
care rounds (70.6%) including active recruitment of failing
PD patients (82.4%). All programs reported that <20% of
acute/urgent dialysis starts initiate HHD, 94.1% of pro-
grams report that <20% of patients followed in pre-dialysis
CKD clinics initiate HHD. Also all programs reported that
almost no one from their in-centre self-care unit transi-
tions to HHD.
There was considerable variability in which profes-
sionals contributed to the initial assessment of potential
home patients. Most programs (94.1%) reported physician
and nurse assessments and a substantial proportion of
programs also incorporated other team members’ input
(58.8% and 52.9% of programs including social workers
and technologists as part of the routine assessment re-
spectively). Patients were not accepted for home HD
training if an exit from the program was anticipated
in <6 months (~1/3 of programs) or <12 months (~1/3
of programs). However, almost ¼ of programs wouldFigure 1 Duties performed by technologists in HHD.accept patients for HHD training regardless of poten-
tial early program exits.Human resources
The majority of programs (57.9%) reported that some al-
lied health team members worked exclusively in the home
dialysis unit (nurses) while others (pharmacists, dieticians,
technologists) were cross-appointed to other parts of the
global dialysis program. Only 5.3% of programs stated that
all allied health team members worked strictly in the HHD
unit. The average patient to professional ratio for each
of the following health professionals: dieticians (152:1),
pharmacists (142:1), social workers (128:1), administrative
clerks (82:1), technologists (23:1) and nurses (16:1) for
programs with these professionals (eg. not all programs
may have had pharmacists). Thirty percent of programs
completely outsourced the technologist support required
for HHD to a vendor or other source. The majority of pro-
grams used a primary nursing model (58.8%) with a shared
nephrologist model (84.2%). For the programs with in-
house technologists, a wide variety of duties were required
of them in different programs (Figure 1).
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Conventional HD machines were used by all of the pro-
grams with maintenance primarily done by in-house
technologists (64.7%). The majority of programs (76.7%)
used reverse osmosis equipment; a few used de-ionizers
(23.5%). The majority of programs (58.8%) used a post-
treatment ultrafilter with some programs adding ultra-
violet light (23.5%). The majority of programs (58.8%)
provided weigh scales and centrifuges (82.4%).
Water
The majority of programs (94.1%) have had experience
with patients using well water with a minority of programs
(35.3%) having had patients using surface water such as
ponds or lakes. There was variability in programmatic al-
lowances for visible microbial counts and maximum
endotoxin concentration of product water for patients’
homes (Figure 2).
Vascular access
The arteriovenous fistula (AVF) was the preferred access
for 88.2% of the programs; 11.8% of programs did not
identify any type of access as preferable over another. The
absence of an AVF did not preclude HHD in any program
though it may delay initiation of HHD training in 37.5% of
programs. In 8 of 17 programs, buttonhole cannulation
was used for all patients with an AVF and all programs
used buttonhole cannulation for at least some patients
(Figure 3). The majority of programs (64.7%) routinely
created 1 set of buttonhole sites (ie. 2 buttonholes) for
patients using this cannulation technique; 23.5% created 2
sets. Steel needles were used by >80% of programs irre-
spective of cannulation method (rope-ladder or button-
hole), while the remainder used Teflon, Supercath or
Angiocath needles. Special safety engineered needles were
mandated by only 31.1% of programs. There was consider-
able variability in routine access monitoring: 5.9% of pro-
grams never monitor flows, 29.4% monitor every 2–3
months, 23.5% monitor at intervals greater than 3 months,Figure 2 Programmatic tolerance limits for water quality. (A) visible m
water in patients’ home HD.and 52.9% monitor only if clinically indicated (responses
are not mutually exclusive). Figure 4 summarizes the
usage of single needle dialysis relative to vascular access
type (fistula versus graft) for patients specifically receiving
NHD; single needle dialysis was relatively more common
among patients with grafts compared to fistulae. For pa-
tients with a central venous catheter (CVCs), 64.5% of
programs used some type of safety connector (eg. TEGO)
to prevent air embolism and 35.3% of programs used con-
nection safety devices such as lock boxes; the remainder
did not mandate the use of any special safety connecto-
logy. CVC’s were locked with citrate or heparin in 64.7%
and 35.3% of programs respectively.
Patient training
The majority of programs (94.1%) used their own pro-
gram-generated training manual and 17.6% supplement
with a self-created video. Most programs (52.9%) also used
industry-generated material. Almost all programs pro-
vided 1:1 nurse-to-patient training (87.5%) that occurred 3
(41.2%), 4 (23.5%) or 5 days (35.3%) per week for 4 to
7 hours per day in the HHD unit (Figure 5). The me-
dian number of weeks to train a patient varied widely
from <4 weeks to >10 weeks. Patients initially educated to
use a CVC for HHD required additional training to tran-
sition to AVF use at home. There was considerable vari-
ability in the amount of time required for access
retraining with 1–3 days, 4–6 days, 7–9 days, >10 days, or
no specific additional training days allocated by 5.9%,
17,6%, 29.4%, 29.4%, and 11.8% of programs respectively.
All programs required that a nurse and/or technologist
accompany a patient during their first self-administered
treatment at home; no program allowed patients to treat
themselves un-supervised for their first home treatment.
Dialysis prescription
The starting prescription for NHD included sodium con-
centration of 136-140 mmol/L, potassium of 2-3 mmol/L,
bicarbonate of 28-37 mmol/L, calcium of 1.25-1.75 mmol/Licrobial counts, and (B) maximum endotoxin concentration in product
Figure 3 Programmatic use of buttonhole cannulation. This graph depicts the number of programs having specific proportions of their AVF
patients who use buttonhole cannulation (ie. 8 programs have all of their AVF patients using buttonholes, while 1 program has <20% of its AVF
patients using buttonholes).
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ranged from 150-500mls/min with both high and low flux
dialyzers being used. The SDHD prescriptions had similar
variability in dialysate composition but uses higher
dialysate flow rates (500-800 mls/min) and all programs
used high flux dialyzers. Few programs prescribed ultra-
filtration profiling (17.6% prescribe occasionally, 82.4%
never) or blood volume monitoring (11.8% occasionally,
88.2% never).Figure 4 Usage of single-needle dialysis for patients undergoing NHDHome treatment requirements and costs
A home assessment to determine the technical feasibility
of conducting HHD was integral to all programs. This was
typically conducted by the technologist from the HHD
program (41.2%), completely outsourced to a third party
such as a dialysis machine vendor (29.4%), or by a com-
bination of technologist and vendor (29.4%). A dedicated
nursing assessment of the home was conducted by 58.8%
of programs. The majority of programs at least partiallyamong: (A) fistula and (B) graft users.
Figure 5 Training schedule. (A) Typical number of days per week a program trains patients, (B) typical number of hours per days a program
trains patients, (C) median number of weeks a patient trains for HHD, and (D) characteristics of patient-to-nurse ratio during HHD training.
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trical renovations (88.2%) though there is considerable
variability in the dollar value (Figure 6). The majority of
programs (58.8%) covered this cost only once. The actual
renovations are typically outsourced (88.2%) or performed
by a combination of program technologist and an out-
sourced tradesperson (11.8%). Some programs (29.4%) ex-
tend their service to a recreational vehicle and/or cottage.
The additional expense of UV lights, iron filters, and water
softeners is born by 35.3%, 41.2%, and 58.8% of programs
respectively; 29.4% of programs report not needing add-
itional water treatment equipment. The additional utilityFigure 6 Estimated average per patient cost for home assessment anexpense incurred by patients dialyzing at home is offset by
only 29.4% of programs.
Besides the technical prerequisites to performing
HHD, 58.8% of programs required that selected HHD
patients had a care partner at home during the treat-
ment, while 41.2% never required such assistants. The
majority of care partners were family members or living
companions (64.7%) though some programs had expe-
rience with paid assistants (47.0%) and unpaid volunteers
(11.8%). Remote real-time monitoring of hemodialysis
treatments was not routine in any program, with 82.4% of
programs reporting never having used this technology andd home renovations born by the HHD program.
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specific circumstances.
Patient follow-up
Although almost all programs (94.1%) had a nurse per-
form a home visit during the first 1–2 treatments, 41.2%
of programs did not schedule subsequent home visits ex-
cept on an as-needed basis with only 35.3% having a fixed
home visit schedule; the remaining programs did not per-
form follow-up nursing home visits. An audit of patient
technique was typically done only if there is an adverse
event at home (41.2%) or at the specific request of the
nurse/nephrologist (35.3%); annual patient “recertifica-
tion” was routine in only 2 of 17 (11.8%) of programs.
The majority of programs (82.3%) had weekly or
monthly follow-up clinics, of which 58.8% of programs
have a dedicated HHD clinic, 35.3% had combined HHD/
PD clinic, and 5.9% had a combined modality and pre-
dialysis care clinic. All programs reported their clinics are
multi-disciplinary in which 88.2% of programs adhered to
a standard checklist of items to be addressed each visit. A
minority of programs (5.9%) offered telehealth clinics for
remote dwelling patients. During the first 3 months of
HHD, patients were usually seen monthly (64.7% of pro-
grams) and then every 2–4 months thereafter (76.5%).
NHD patients were asked to draw routine blood work ei-
ther once or twice monthly by 35.3% and 58.8% of pro-
grams respectively. The frequency of routine blood work
for SDHD patients was similar. Patients receiving home
conventional HD were doing blood work only once per
month in nearly all programs (92.1%). Most programs
(70.6%) taught their patients to draw their own blood
(including centrifugation), 29.4% of programs had their
patients blood work drawn at a local laboratory. Figure 7
summarizes the type and timing of blood work specifically
requested for NHD patients, with some tests being per-
formed only pre-dialysis (CBC) and others both pre- and
post-dialysis (urea and/or creatinine, and calcium and
phosphate). A significant proportion of programs (29.4%)
did not monitor post-dialysis calcium and phosphate for
their NHD patients.
Figure 8 outlines the availability of on-call staff to
HHD patients among Canadian HHD programs. The
majority of programs had designated nurses, technolo-
gists and nephrologists on-call for troubleshooting HHD
problems. Whether a nurse and a technologist are on-
call was not mutually exclusive so a program may have
one or both professionals available at a given time. The
questionnaire did not specifically address if no one was
on-call during a given time period.
Medications
Tapering schedules for anti-hypertensive medications
and phosphate binders for more frequent HHD patientswas predominately managed on an ad-hoc basis (in
76.5% and 64.7% of programs respectively). Fifty-three
percent of programs adjusted phosphate binders or add
supplemental phosphate to the dialysate based on pre-
and post-dialysis serum phosphate concentrations, while
47.1% of programs made these decisions based solely on
the pre-dialysis phosphate level.
Self-administration of intravenous iron and antibiotics
was allowed by 93% and 76.5% of programs. A minority of
programs (16.6%) routinely provided their patients using
CVCs a first dose of an empiric antibiotic to be kept at
home for self-administration at the first sign of infection.
Only 37.5% of programs allowed patients to self-treat with
plasminogen activator (tPA). The proportion of HHD pro-
grams paying for the following medications was: cinacalcet
(17.6% of programs pay), supplemental phosphate to dia-
lysate (88.2%), supplemental calcium to dialysate (76.5%),
phosphate binders (35.3%), tPA (88.2%), intravenous anti-
biotics (76.5%), erythropoietin (70.6%), and intravenous
iron (88.2%). This questionnaire did not address who does
pay for these medications if not the HHD program (ie.
hospital pharmacy, patient, private insurer, etc.).
Non-adherent patients
Almost all programs cited non-adherence issues in their
programs. The most frequent was skipped treatments
(reported by 82.4% of programs). Other issues included
not taking prescribed medications (76.5%), not performing
machine maintenance (70.6%), skipping blood work and
missing clinics (each by 64.7% of programs), unreachable
by telephone for important follow-up and not following
direct instructions by on-call personnel (each by 58.8% of
programs), and refusing home visits (35.3%). Approxi-
mately two-thirds of physician HHD directors agreed with
the statement “competent patients are entitled to make
decisions that clinicians think are unsafe” even though
70.6% of programs reported having removed a patient
from HHD due to non-adherence (against the patient’s
wishes). Almost none of the programs have a written
policy for dealing with non-adherence (82.4%).
To our knowledge this the first large-scale practice pat-
tern survey for the delivery of HHD across experienced
programs with input from multi-disciplinary teams. The
fact that considerable practice pattern variation was docu-
mented across almost all surveyed domains underscores
the paucity of high quality evidence to guide clinical care.
These results will serve as a basis of comparison among
Canadian HHD programs, as well as benchmark the
Canadian experience to international HHD practices.
Importantly, these survey results should not be viewed
as practice recommendations. The variation described re-
flects how individual programs have adapted their previous
experiences with home-based hemodialysis from an earlier
era with their contemporary interest in intensification of
Figure 7 Timing and nature of routine blood work performed by NHD patients. Proportion of programs requiring specific blood work
pre- and/or post-dialysis.
Figure 8 On-call availability directly to HHD patients. (A) Monday-Friday during regular working hours, (B) Monday-Friday evenings, (C) overnight,
and (D) weekends. The availability of different professionals is not mutually exclusive; a program may provide simultaneous coverage with a nurse
and technologist, or a nurse or a technologist. These data cannot be used to conclude that some programs provide no coverage during certain
time periods.
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veniently delivered at home.
This survey explored 11 practice domains yielding
considerable data of interest to nephrologists, nurses,
technologists, administrators, policy makers and pa-
tients. Not all of these results can be discussed in detail
so we highlight a few salient observations that warrant
broader consideration. First, there was significant varia-
tion in uptake of both HHD and PD in Canada. It is not-
able that success in delivering both HHD and PD can be
demonstrated in both academic and community settings
with examples of a combined prevalent home therapies
population of 35-45% among both types of practices
(Table 1). The fact that the prevalence of HHD among 3
of 5 community programs is ~10% also suggests that
NHD and SDHD have emerged from the realm of
experimental therapies and are well-established main-
stream treatments in Canada.
Our results highlight considerable variation in program-
matic policy when considering patients such as potential
living transplant recipients who might be expected to exit
HHD prior to 12 months. This is likely based on a pro-
gram’s interpretation of data suggesting that the financial
breakeven point for managing a patient on HHD occurs
after about one year [15]; presumably some programs
place a high value on this while others do not. A program’s
success with potential living donors actually becoming do-
nors and the time involved in the work-up algorithm may
also impact on acceptance to HHD training.
The observation that only a small minority of incident
ESRD patients from pre-dialysis clinics, self-care units,
and urgent dialysis starters will commence either NHD or
SDHD represents a system-wide opportunity to speci-
fically target these populations with interventions aimed
to educate and convert these patients to HHD (or home
therapies generally).
At the time of this survey, the Canadian standards for
HHD water quality had not been published which pre-
sumably led to more variation in the action limits for
CFU/ml and EU/ml [16]. However, there may be a sub-
stantial increase in cost associated with implementing
these standards and how this impacts potential HHD
patients with surface water as their only feed water
source is not known. It is unclear what the quality of life
and morbidity/mortality trade-offs are for implementing
standards that have not been shown to impact either of
those outcomes.
Buttonhole cannulation remains common among
Canadian HHD programs and while the AVF is the pre-
ferred vascular access, there is a common conviction that
it remains preferable to have patients self-manage their
dialysis at home irrespective of access. It should be noted
that this survey was conducted prior to the publication
of the Canadian Society of Nephrology (CSN) clinicalpractice guidelines on intensive HHD [17,18]. These
guidelines dissuade the preferential use of buttonhole
cannulation based on emerging literature suggesting that
buttonholes pose an increased risk for local and systemic
infectious complications over traditional rope-ladder can-
nulation. Whether these guidelines will alter practice
remains to be seen since buttonhole cannulation is per-
ceived as an important convenience in HHD and the
quality of evidence against their use is poor. These guide-
lines also encourage the use of fistulae over other vascular
access, but acknowledge that almost no data specific to in-
tensive HHD supports (or refutes) this stance.
The survey reveals the common practice of prescribing
single-needle dialysis among HHD patients, particularly
among patients with arteriovenous grafts but also those
with fistulae. This is presumably out of concern that fre-
quent cannulation of a graft will eventually wear out the
synthetic material resulting in access complications, and
the worry that inadvertent needle dislodgement in a
double-needle setup could result in rapid exsanguination.
Neither fear has born out in almost 2 decades of intensive
NHD experience in Canada [19]. While patients per-
forming single-needle HHD may experience the less
objective advantages from dialyzing at home (eg. flexible
schedule, increased locus of control, quality of life, etc.),
the biochemical benefit of this dialysis may be overesti-
mated even for long duration treatments compared with
double-needle dialysis. To our knowledge, the trade-offs
of single- versus double-needle dialysis in the home inten-
sive HD setting have not been systematically investigated.
While all but 2 of 17 Canadian programs surveyed reim-
burse some or all of the expenses for plumbing and elec-
trical renovations required to perform HHD, considerable
costs for dialysis are still transferred to the patient. These
include non-reimbursed renovation expenses, additional
utility cost incurred by running dialysis and water treat-
ment equipment, and in many cases, to incidental costs of
scales, additional water purifiers, etc. A question of equity
versus in-centre dialysis is raised if these expenses are not
offset by transportation cost savings, especially since wide-
spread reimbursement for the incremental cost of HHD is
uncommon in Canada.
Finally, there is considerable variability in the frequency
and timing of routine blood work, especially for NHD pa-
tients. This is particularly true for calcium and phosphate
which 70% of programs measure pre- and post-dialysis
while 30% measure only pre-treatment. This lack of
consensus underscores our fundamental lack of under-
standing how post-dialysis concentrations (especially of
phosphate) should be interpreted. The aforementioned
CSN guidelines also attest to this knowledge gap by sug-
gesting that dialysate be supplemented with phosphate to
keep pre-dialysis phosphate in the normal range and post-
dialysis phosphate above 0.40-0.70 mmol/L, although this
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on the theoretical risk of hypophosphatemia and very
poor quality evidence [18].
While this survey was systematically designed and had
strong national participation in its inception and con-
duct, there are a number of important limitations to be
acknowledged. The survey instrument did not undergo
rigorous testing for validity and reliability. Because it
was intended to cover broadly many domains, it could
not address in detail any one domain without inducing
respondent fatigue. As with any survey, reliance on self-
reporting by HHD medical directors on behalf of their
unit may not reflect the true practice within the pro-
gram. In an attempt to avoid this bias, program leads
were asked to include allied health team members in
completing this questionnaire. This survey also does not
capture the institutional culture that encourages the up-
take of HHD, which is presumably a dominant predictor
of HHD success, irrespective of practice pattern. Lastly,
the results of this survey are now more than 2 years old
and practices may have changed during that time.
Conclusion
This survey of Canadian practice patterns demonstrates
considerable variability in how HHD is conducted. Whe-
ther such variation contributes to differential uptake of
HHD among programs cannot be concluded from these
data. Since programmatic differences in HHD may have
an impact on a patient and family’s success within the pro-
gram, the extent to which programmatic differences in
practices contribute to patient dropout and survival in
HHD is currently under investigation. In the future, our
survey could also be used to explore programmatic dif-
ferences by patient location (rural versus urban, province,
country) and centre type.
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